Inner Circle - Astute Investor's Calculus

This category can only be viewed by members.

[Inner Circle] Squeeze Dollars from Oil

Research / Shailesh Kumar, MBA / September 1, 2025

VLCC tanker charter rates are spiking – Source: Fearnleys Tanker operators move oil from point A to point B. This simple business model goes through cycles. A typical Demand cycle looks like this: Cash flows like water: The daily charter rates are high and the ships are fully booked. The operators are generate spectacular amounts of […]

To access this post, you must purchase Astute Investor’s Calculus: Inner Circle Investment Subscription (1 Year Access).

[Inner Circle] Squeeze Dollars from Oil Read More »

[Inner Circle] 🏰 PEP — PepsiCo, Inc. A 53-Year Dividend Growth Streak, Attractively Priced

Research / Shailesh Kumar, MBA / July 23, 2025

🟦 Introduction Pepsi just reported better than expected earnings and saw its stock pop 6% on the news. It now also forecasts smaller annual earnings decline than previously forecasted. This comes after a period of declining sales and earnings in response to the launch of GLP-1 as well as the impact of the new focus

To access this post, you must purchase Astute Investor’s Calculus: Inner Circle Investment Subscription (1 Year Access).

[Inner Circle] 🏰 PEP — PepsiCo, Inc. A 53-Year Dividend Growth Streak, Attractively Priced Read More »

AIC Portfolios – Outperforming the Market in First Half

Portfolio Update / Shailesh Kumar, MBA / July 9, 2025

The first half of the year is done and dusted. The markets have been all over the place, but all our portfolios have performed extremely well. We have not only beat the S&P 500 in 3 out of 4 portfolios (and were in line with the market in the 4th portfolio), but our flagship Small

To access this post, you must purchase Astute Investor’s Calculus: Inner Circle Investment Subscription (1 Year Access).

AIC Portfolios – Outperforming the Market in First Half Read More »

[Inner Circle] The Next Berkshire Hathaway, Part 3, Final

Research / Shailesh Kumar, MBA / July 1, 2025

We continue with our review of the company I consider the next Berkshire Hathaway. In this 3rd and final post, I look at the component businesses and arrive at a sum of the parts valuation for the company. As a result, I find that the stock today is selling at 39% discount to the fair

To access this post, you must purchase Astute Investor’s Calculus: Inner Circle Investment Subscription (1 Year Access).

[Inner Circle] The Next Berkshire Hathaway, Part 3, Final Read More »

[Inner Circle] The Next Berkshire Hathaway – Part 2, The Financials

Research / Shailesh Kumar, MBA / June 8, 2025

Previously I introduced the company I am positing as the next Berkshire Hathaway. This is a call I do not make lightly, and therefore, the research is deeper and more extensive. After all, we are looking at something we might hold for decades. If you have not read the Part 1, you can do so

To access this post, you must purchase Astute Investor’s Calculus: Inner Circle Investment Subscription (1 Year Access).

[Inner Circle] The Next Berkshire Hathaway – Part 2, The Financials Read More »

[Inner Circle] The Next Berkshire Hathaway – Part 1

Research / Shailesh Kumar, MBA / June 3, 2025

It takes a special kind of company to be crowned the Next Berkshire Hathaway, and I believe I have found one. Warren Buffett invested in this company and sat on its Board for 37 years. Tom Gayner from Markel is a current Director. The management of the company is disciplined and plays for the long

To access this post, you must purchase Astute Investor’s Calculus: Inner Circle Investment Subscription (1 Year Access).

[Inner Circle] The Next Berkshire Hathaway – Part 1 Read More »

[Inner Circle] $VTRS – Viatris, a Low Hanging Fruit in the Pharmaceutical Industry

Research / Shailesh Kumar, MBA / April 27, 2025

[This article was originally published on Apr 27, 2025] Martin Shkreli, the poster boy for pharma greed, criticized this company at the rate it was raising its prices for EpiPen. On 2009 the wholesale price of two EpiPens was about $100, by July 2013 the price was about $265, in May 2015 it was around

To access this post, you must purchase Astute Investor’s Calculus: Inner Circle Investment Subscription (1 Year Access).

[Inner Circle] $VTRS – Viatris, a Low Hanging Fruit in the Pharmaceutical Industry Read More »

[Inner Circle] $SNA – Dividend Fortress Portfolio Stock Review

Research / Shailesh Kumar, MBA / March 20, 2025

[This analysis was originally published on March 20, 2025] You can build an industrial behemoth with a single idea. This is what this company did. They started out building interchangeable handles and sockets for the automotive repair industry in 1920. Automobiles were just catching on and repair was a growing market. Pretty soon, they started

To access this post, you must purchase Astute Investor’s Calculus: Inner Circle Investment Subscription (1 Year Access).

[Inner Circle] $SNA – Dividend Fortress Portfolio Stock Review Read More »

[Inner Circle] $SCVL – Small Cap Value with Growth Characteristics

Research / Shailesh Kumar, MBA / March 2, 2025

[This report was originally published on March 2, 2025] 20% of the stock of this small cap company has been shorted. A whole lot of investors expect the company to fail. The stock price has declined 31% in the last 1 year. For a contrarian, this may be enough to take a position against the

To access this post, you must purchase Astute Investor’s Calculus: Inner Circle Investment Subscription (1 Year Access).

[Inner Circle] $SCVL – Small Cap Value with Growth Characteristics Read More »

[Inner Circle] $CE – This Stock Just Bottomed—Here’s Why the Next Move Could Be Explosive

Research / Shailesh Kumar, MBA / January 29, 2025

[This article was originally posted on January 29, 2025] Bank of America Sees Market Bottoming for This Chemical Giant in 2025 Bank of America upgraded this stock from Underperform to Buy on January 14, 2025. That’s a major shift—how often do you see analysts leapfrogging multiple rating levels in one go? Why the Sudden Upgrade? Let’s Look at the Facts

To access this post, you must purchase Astute Investor’s Calculus: Inner Circle Investment Subscription (1 Year Access).

[Inner Circle] $CE – This Stock Just Bottomed—Here’s Why the Next Move Could Be Explosive Read More »